• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-mpl基因缺陷小鼠中的血小板减少症。

Thrombocytopenia in c-mpl-deficient mice.

作者信息

Gurney A L, Carver-Moore K, de Sauvage F J, Moore M W

机构信息

Department of Molecular Biology, Genentech, South San Francisco, CA 94080.

出版信息

Science. 1994 Sep 2;265(5177):1445-7. doi: 10.1126/science.8073287.

DOI:10.1126/science.8073287
PMID:8073287
Abstract

Thrombopoietin (TPO) is a cytokine that is involved in the regulation of platelet production. The receptor for TPO is c-Mpl. To further investigate the role and specificity of this receptor in regulating megakaryocytopoiesis, c-mpl-deficient mice were generated by gene targeting. The c-mpl-/- mice had an 85 percent decrease in their number of platelets and megakaryocytes but had normal amounts of other hematopoietic cell types. These mice also had increased concentrations of circulating TPO. These results show that c-mpl specifically regulates megakaryocytopoiesis and thrombopoiesis through activation by its ligand TPO.

摘要

血小板生成素(TPO)是一种参与血小板生成调节的细胞因子。TPO的受体是c-Mpl。为了进一步研究该受体在调节巨核细胞生成中的作用和特异性,通过基因靶向技术构建了c-mpl基因缺陷小鼠。c-mpl基因敲除小鼠的血小板和巨核细胞数量减少了85%,但其他造血细胞类型的数量正常。这些小鼠循环中的TPO浓度也有所升高。这些结果表明,c-Mpl通过其配体TPO的激活特异性地调节巨核细胞生成和血小板生成。

相似文献

1
Thrombocytopenia in c-mpl-deficient mice.c-mpl基因缺陷小鼠中的血小板减少症。
Science. 1994 Sep 2;265(5177):1445-7. doi: 10.1126/science.8073287.
2
[Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].[血小板生成素及其受体c-Mpl在血小板减少症血小板生成调控中的意义]
Klin Padiatr. 1996 Jul-Aug;208(4):168-71. doi: 10.1055/s-2008-1046468.
3
Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.c-Mpl细胞内结构域远端一半在体内血小板生成素控制血小板生成中的作用。
Mol Cell Biol. 2000 Jan;20(2):507-15. doi: 10.1128/MCB.20.2.507-515.2000.
4
c-mpl, the thrombopoietin receptor.c-mpl,即血小板生成素受体。
Thromb Haemost. 1995 Jul;74(1):526-8.
5
High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.血小板和巨核细胞中Mpl的高水平表达独立于血小板生成素。
Blood. 1999 May 1;93(9):2859-66.
6
The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.c-mpl基因缺陷小鼠中的残余巨核细胞和血小板生成并不依赖于白细胞介素-6、白细胞介素-11或白血病抑制因子的作用。
Blood. 2000 Jan 15;95(2):528-34.
7
[Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].先天性无巨核细胞血小板减少症(CAMT)——血小板生成素受体c-Mpl的缺陷
Klin Padiatr. 2001 Jul-Aug;213(4):155-61. doi: 10.1055/s-2001-16846.
8
Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.在人CD34细胞和血小板中表达的新型c-mpl变体的克隆与功能特性分析
Cytokine. 2000 Jul;12(7):835-44. doi: 10.1006/cyto.1999.0654.
9
Thrombopoietin and the humoral regulation of thrombocytopoiesis.血小板生成素与血小板生成的体液调节
Curr Opin Hematol. 1995 May;2(3):167-71. doi: 10.1097/00062752-199502030-00002.
10
The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.内皮细胞上表达的Mpl受体对循环中血小板生成素水平的调节作用不大。
Exp Hematol. 2006 Jan;34(1):82-6. doi: 10.1016/j.exphem.2005.09.008.

引用本文的文献

1
Structural basis of MPL activation by thrombopoietin.血小板生成素激活MPL的结构基础。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(3):100018. doi: 10.1016/j.bvth.2024.100018. eCollection 2024 Sep.
2
Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo.小分子BLVRB氧化还原抑制剂在体内促进巨核细胞生成和应激性血小板生成。
Nat Commun. 2025 Apr 11;16(1):3480. doi: 10.1038/s41467-025-58497-9.
3
cMPL-based purification and depletion of human hematopoietic stem cells: implications for pretransplant conditioning.
基于cMPL的人造血干细胞纯化与去除:对移植前预处理的影响
Blood. 2025 Jun 19;145(25):2978-2991. doi: 10.1182/blood.2024024636.
4
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.人类对多种疫苗抗体反应持久性的预测因素和机制的系统疫苗学分析。
Nat Immunol. 2025 Jan;26(1):116-130. doi: 10.1038/s41590-024-02036-z. Epub 2025 Jan 2.
5
Lung megakaryocytes engulf inhaled airborne particles to promote intrapulmonary inflammation and extrapulmonary distribution.肺巨核细胞吞噬吸入的空气传播颗粒,以促进肺内炎症和肺外分布。
Nat Commun. 2024 Aug 27;15(1):7396. doi: 10.1038/s41467-024-51686-y.
6
G2 arrest primes hematopoietic stem cells for megakaryopoiesis.G2 期阻滞促进造血干细胞向巨核细胞分化。
Cell Rep. 2024 Jul 23;43(7):114388. doi: 10.1016/j.celrep.2024.114388. Epub 2024 Jun 26.
7
PI3K/HSCB axis facilitates FOG1 nuclear translocation to promote erythropoiesis and megakaryopoiesis.PI3K/HSCB 轴促进 FOG1 核转位以促进红细胞生成和巨核细胞生成。
Elife. 2024 May 17;13:RP95815. doi: 10.7554/eLife.95815.
8
Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia.染料木苷:一种靶向雌激素受体β以缓解血小板减少症的新型雌激素类似物。
Int J Biol Sci. 2024 Mar 25;20(6):2236-2260. doi: 10.7150/ijbs.90483. eCollection 2024.
9
Modifying platelets at their birth: anti-thrombotic therapy without haemorrhage.在血小板生成时进行改造:无出血风险的抗血栓治疗。
Front Pharmacol. 2024 Mar 18;15:1343896. doi: 10.3389/fphar.2024.1343896. eCollection 2024.
10
The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.血小板在肿瘤微环境中的定位、起源和影响取决于肿瘤类型。
J Exp Clin Cancer Res. 2024 Mar 16;43(1):84. doi: 10.1186/s13046-024-03001-2.